Log in
NASDAQ:AZN

AstraZeneca Stock Forecast, Price & News

$51.57
-0.62 (-1.19 %)
(As of 10/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$50.47
Now: $51.57
$52.48
50-Day Range N/A
52-Week Range
$36.15
Now: $51.57
$64.94
Volume8.21 million shs
Average Volume5.14 million shs
Market Capitalization$135.35 billion
P/E Ratio62.13
Dividend Yield1.69%
Beta0.52
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.75 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AZN
CUSIPN/A
CIKN/A
Phone44 20 3749 5000
Employees70,600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$24.38 billion
Cash Flow$3.08 per share
Book Value$5.56 per share

Profitability

Net Income$1.34 billion

Miscellaneous

Outstanding Shares2,624,593,000
Market Cap$135.35 billion
Next Earnings Date11/5/2020 (Confirmed)
OptionableOptionable
$51.57
-0.62 (-1.19 %)
(As of 10/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AZN News and Ratings via Email

Sign-up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AstraZeneca (NASDAQ:AZN) Frequently Asked Questions

When is AstraZeneca's next earnings date?

AstraZeneca is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for AstraZeneca
.

How were AstraZeneca's earnings last quarter?

AstraZeneca PLC (NASDAQ:AZN) posted its quarterly earnings data on Thursday, July, 30th. The company reported $0.48 EPS for the quarter, beating the consensus estimate of $0.44 by $0.04. The business had revenue of $6.28 billion for the quarter, compared to analysts' expectations of $6.25 billion. AstraZeneca had a net margin of 8.36% and a return on equity of 37.72%.
View AstraZeneca's earnings history
.

Has AstraZeneca been receiving favorable news coverage?

News headlines about AZN stock have been trending somewhat positive on Thursday, according to InfoTrie Sentiment. The research group scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. AstraZeneca earned a daily sentiment score of 0.7 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future.
View the latest news about AstraZeneca
.

Who are some of AstraZeneca's key competitors?

What other stocks do shareholders of AstraZeneca own?

Who are AstraZeneca's key executives?

AstraZeneca's management team includes the following people:
  • Mr. Pascal Soriot D.V.M., M.B.A., CEO & Exec. Director (Age 61)
  • Mr. Marc Dunoyer, CFO & Exec. Director (Age 68)
  • Ms. Pam P. Cheng, Exec. Vice-Pres of Operations & Information Technology (Age 49)
  • Prof. Ralph Knöll, Chief Scientist
  • Thomas Kudsk Larsen, Head of Investor Relations

What is AstraZeneca's stock symbol?

AstraZeneca trades on the NASDAQ under the ticker symbol "AZN."

How do I buy shares of AstraZeneca?

Shares of AZN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AstraZeneca's stock price today?

One share of AZN stock can currently be purchased for approximately $51.57.

How big of a company is AstraZeneca?

AstraZeneca has a market capitalization of $135.35 billion and generates $24.38 billion in revenue each year. The company earns $1.34 billion in net income (profit) each year or $1.75 on an earnings per share basis. AstraZeneca employs 70,600 workers across the globe.

What is AstraZeneca's official website?

The official website for AstraZeneca is www.astrazeneca.com.

How can I contact AstraZeneca?

AstraZeneca's mailing address is 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE X0, CB2 0AA. The company can be reached via phone at 44 20 3749 5000 or via email at [email protected]

This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.